Elizabeth Austic1, Sean Esteban McCabe, Sarah A Stoddard, Quyen Epstein Ngo, Carol Boyd. 1. Department of Emergency Medicine (EA), University of Michigan, Ann Arbor, MI; Institute for Research on Women and Gender (SEM, QEN, CB), University of Michigan, Ann Arbor, MI; School of Nursing (SAS, CB), University of Michigan, Ann Arbor, MI; Injury Research Center and Michigan Institute for Clinical and Health Research (QEN), University of Michigan, Ann Arbor, MI; and Addiction Research Center (CB), University of Michigan, Ann Arbor, MI.
Abstract
OBJECTIVES: We identified peak annual incidence rates for medical and nonmedical use of prescription opioid analgesics, stimulants, sedatives, and anxiolytics (controlled medication), and explored cohort effects on age of initiation. METHODS: Data were gathered retrospectively between 2009 and 2012 from Detroit area students (n = 5185). Modal age at the last assessment was 17 years. A meta-analytic approach produced age-, year-, and cohort-specific risk estimates of first-time use of controlled medication. Cox regression models examined cohort patterns in age of initiation for medical and nonmedical use with any of 4 classes of controlled medication (opioid analgesics, stimulants, sedatives, or anxiolytics). RESULTS: Peak annual incidence rates were observed at age 16 years, when 11.3% started medical use, and 3.4% started using another person's prescription for a controlled medication (ie, engaged in nonmedical use). In the more recent birth cohort group (1996-2000), 82% of medical users and 76% of nonmedical users reported initiating such use by age 12 years. In contrast, in the less recent birth cohort group (1991-1995), 42% of medical users and 35% of nonmedical users initiated such use by age 12 years. Time to initiation was 2.6 times less in the more recent birth cohort group (medical use: adjusted hazard ratio [aHR] = 2.57 [95% confidence interval {CI} = 2.32-2.85]; nonmedical use: aHR = 2.57 [95% CI = 2.17-3.03]). CONCLUSIONS: Peak annual incidence rates were observed at age 16 years for medical and nonmedical use. More recent cohorts reported initiating both types of use at younger ages. Earlier interventions may be needed to prevent adolescent nonmedical use of controlled medication.
OBJECTIVES: We identified peak annual incidence rates for medical and nonmedical use of prescription opioid analgesics, stimulants, sedatives, and anxiolytics (controlled medication), and explored cohort effects on age of initiation. METHODS: Data were gathered retrospectively between 2009 and 2012 from Detroit area students (n = 5185). Modal age at the last assessment was 17 years. A meta-analytic approach produced age-, year-, and cohort-specific risk estimates of first-time use of controlled medication. Cox regression models examined cohort patterns in age of initiation for medical and nonmedical use with any of 4 classes of controlled medication (opioid analgesics, stimulants, sedatives, or anxiolytics). RESULTS: Peak annual incidence rates were observed at age 16 years, when 11.3% started medical use, and 3.4% started using another person's prescription for a controlled medication (ie, engaged in nonmedical use). In the more recent birth cohort group (1996-2000), 82% of medical users and 76% of nonmedical users reported initiating such use by age 12 years. In contrast, in the less recent birth cohort group (1991-1995), 42% of medical users and 35% of nonmedical users initiated such use by age 12 years. Time to initiation was 2.6 times less in the more recent birth cohort group (medical use: adjusted hazard ratio [aHR] = 2.57 [95% confidence interval {CI} = 2.32-2.85]; nonmedical use: aHR = 2.57 [95% CI = 2.17-3.03]). CONCLUSIONS: Peak annual incidence rates were observed at age 16 years for medical and nonmedical use. More recent cohorts reported initiating both types of use at younger ages. Earlier interventions may be needed to prevent adolescent nonmedical use of controlled medication.
Authors: Sean Esteban McCabe; Brady T West; Christian J Teter; Paula Ross-Durow; Amy Young; Carol J Boyd Journal: Drug Alcohol Depend Date: 2011-06-12 Impact factor: 4.492
Authors: Kathleen L Egan; Eric Gregory; Mark Wolfson; Vincent T Francisco; Robert W Strack; David L Wyrick; Michael A Perko Journal: J Child Adolesc Subst Abuse Date: 2019-04-22
Authors: Sean Esteban McCabe; Deborah D Kloska; Philip Veliz; Justin Jager; John E Schulenberg Journal: Addiction Date: 2016-08-09 Impact factor: 6.526
Authors: Jason D Wright; Jacob C Cogan; Yongmei Huang; Ana I Tergas; Caryn M St Clair; June Y Hou; Fady Khoury-Collado; Allison Gockley; Melissa Accordino; Alexander Melamed; Dawn L Hershman Journal: JAMA Netw Open Date: 2021-06-01
Authors: Lisa A Marsch; Sarah K Moore; Michael Grabinski; Sarah Y Bessen; Jacob Borodovsky; Emily Scherer Journal: JMIR Public Health Surveill Date: 2021-02-25
Authors: Cindy D Chang; Mohsen Saidinejad; Zaza Atanelov; Ann M Dietrich; Samuel Hiu-Fung Lam; Emily Rose; Tim Ruttan; Sam Shahid; Michael J Stoner; Carmen Sulton; Corrie E Chumpitazi Journal: J Am Coll Emerg Physicians Open Date: 2021-07-21
Authors: Lorraine I Kelley-Quon; Matthew G Kirkpatrick; Robert L Ricca; Robert Baird; Calista M Harbaugh; Ashley Brady; Paula Garrett; Hale Wills; Jonathan Argo; Karen A Diefenbach; Marion C W Henry; Juan E Sola; Elaa M Mahdi; Adam B Goldin; Shawn D St Peter; Cynthia D Downard; Kenneth S Azarow; Tracy Shields; Eugene Kim Journal: JAMA Surg Date: 2021-01-01 Impact factor: 14.766